News Focus
News Focus
Followers 9
Posts 680
Boards Moderated 0
Alias Born 11/22/2003

Re: None

Thursday, 06/24/2010 10:52:53 AM

Thursday, June 24, 2010 10:52:53 AM

Post# of 53982
First American Scientific's OPS Ranking of "2" Reiterated by StockDiagnostics.com

Sarasota, FL, June 9, 2010-StockDiagnostics.com announced that it has reiterated its OPS Ranking of "2" for First American Scientific Corporation (OTC:FASC). First American Scientific has had an OPS Ranking of "2" for three consecutive quarters.

StockDiagnostics.com's maintaining of the OPS RankingTM is based on First American Scientific's recently filed Cash Flow Statements for its quarter ended March 31, 2010. The company's computed OPS TM (Operational-cashflow Per Share) for the quarter was $-0.001 per share as compared to $-0.0001 per share for the comparable year earlier quarter. OPS for the most recent 12 months ended March 31, 2010 was $0.0004 per share as compared to $0.001 per share for the 12 months ended March 31, 2009. OPS for First American Scientific's trailing twelve months reached a two year low.

The shares of First American Scientific were recently trading at $0.04, which is within 15% of their one year high of $0.05 on May 12, 2010.

“OPS Rankings” originated from the results of an in-depth 1990-2001, research study on Operational Cashflow that was done by StockDiagnostics.com. The study included 3,885 public companies, whose shares traded at a minimum of $6.00 per share in 1999 and also filed their four quarterly reports for fiscal 1999. The findings revealed that each of the company’s “OPS” logically fell into one of eight distinctive risk categories. The categories were the genesis of StockDiagnostics.com’s numerical eight point, 1 through 8, OPS rankings.

The ranking of 2, which the company received means that First American Scientific based on its OPS over its most recent four quarters and its aggregated OPS over its latest twelve months is in the second lowest risk category. The results from the study indicated that 81.86% of all the companies in this risk category (an OPS Ranking of 2), which had shares that traded at $6.00 or above in 1999 had share prices, which traded at $6.00 or above during 2001.

Statistical research on the other OPS Rankings is available at www.StockDiagnostics.com and is also available at StockTrendNews.com. Additional information on StockDiagnostics, its OPS Rankings and on OPS, including three minute web tutorials, “What is OPS?” and “What are OPS Ratings?”, are available at www.StockDiagnostics.com.

About StockDiagnostics.com -- StockDiagnostics.com covers approximately 10,000 publicly traded companies and 216 industries. It provides current and archived OPS Rankings and its proprietary OPS 4 Quarter, 20 Quarter and 5 Year charts on each company and each industry four times per year. Statistical research on the other OPS Rankings is available at www.StockDiagnostics.com and is also available at StockTrendNews.com. StockDiagnostics.com also provides 20 Quarter and 5 Year extended data table “Free Cash Pro” charts which track EBITDA, Free Cash Flow and Cash Flow From Operations (CFFO). These charts are primarily used by analysts and professional investors.

StockDiagnostics.com has access to a proprietary data refinery that automates the process of collecting, sorting and organizing large amounts of securities pricing and financial data into comparative financial ratios. These ratios are used to identify Financial Statement anomalies and securities pricing variances to monitor changes in the performance of public companies. Go to www.StockDiagnostics.com for a description of StockDiagnostics.com's patent-pending technical applications, such as OPS, OPS Rankings, The EPS Syndrome and more. Three minute videos on OPS and OPS rankings are available at www.StockDiagnostics.com.

http://finance.boston.com/boston/action/linkout?URL=http://www.StockTrendNews.com/753961&Title=Latest+OPS+Ranking+for+First+American+Scientific+released+by+StockDiagnostics.com

Copyright 2010 StockTrendNews.com

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today